Search results
Windlas Biotech IPO is a book built issue of Rs 401.54 crores. The issue comprises of fresh issue of Rs 165.00 crore and offer for sale of 0.51 crore shares. Windlas Biotech IPO bidding started from August 4, 2021 and ended on August 6, 2021.
Aug 4, 2021 · August 04, 2021 / 12:03 PM IST. Windlas Biotech, the domestic pharmaceutical formulations contract development and manufacturing organization, is going to open its initial public offering this...
Aug 4, 2021 · Windlas Biotech IPO: The initial public offering (IPO) of Windlas Biotech, a manufacturer of pharmaceutical formulations, will open for subscription on Wednesday, August 4, 2021, at a price band of Rs 448-460 per share of the face value of Rs 5 each. The offer will be available till Friday, August 6, 2021.
Aug 2, 2021 · Windlas Biotech IPO comprises fresh issuance of equity shares worth ₹165 crore and and an offer for sale of up to 5,142,067 equity shares.
Aug 10, 2021 · Windlas Biotech IPO GMP today is ₹80, which is around 17 per cent higher from its issue price band of ₹448 to ₹460. Windlas Biotech IPO: Bidders can check Windlas Biotech IPO allotment status...
Windlas Biotech IPO is a public issue of 6,136,252 equity shares. The issue offers 3,088,786 shares to retail investors, 1,723,700 shares to qualified institutional buyers, and 1,323,766 shares to non-institutional investors.
Jul 29, 2021 · The initial public offer (IPO) of Windlas Biotech Limited offers an early investment opportunity in Windlas Biotech Limited. A stock market investor can buy Windlas Biotech IPO shares by applying in IPO before Windlas Biotech Limited shares get listed at the stock exchanges.
